@article{ATM2930,
author = {Jacqueline A. Shaw and Justin Stebbing},
title = {Circulating free DNA in the management of breast cancer},
journal = {Annals of Translational Medicine},
volume = {2},
number = {1},
year = {2013},
keywords = {},
abstract = {Circulating cell-free DNA (cfDNA) is now under investigation as a “liquid biopsy” in the real time management of cancer. In The New England Journal of Medicine Dawson et al. reported a proof of concept investigation of tumour specific alterations in cfDNA and demonstrate that this fraction termed “circulating tumour DNA” (ctDNA) shows greater correlation with changes in tumour burden than two other circulating biomarkers (CA 15-3 and circulating tumor cell counts) in individuals with metastatic breast cancer receiving therapy.},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/2930}
}